Global Biosurgery Market Size Study & Forecast, by Product (Surgical Sealants, Hemostatic Agents, Adhesion Barriers, Soft Tissue Attachments) and Application (General Surgery, Orthopedic Surgery) and Regional Forecasts 2025-2035

The Global Biosurgery Market, valued at approximately USD 26.9 billion in 2024, is set to expand at a robust CAGR of 4.70% from 2025 to 2035. Biosurgery encompasses a sophisticated portfolio of advanced medical products designed to minimize intraoperative and postoperative complications, promote natural healing processes, and enhance surgical outcomes. These solutions, ranging from surgical sealants and hemostatic agents to adhesion barriers and soft tissue attachments, have become indispensable in modern operating rooms, addressing complex surgical needs in both routine and high-risk procedures. The market growth is being driven by a surge in surgical volumes worldwide, owing to an aging population, an increase in trauma and sports injuries, and the rising prevalence of chronic conditions that necessitate surgical intervention. Additionally, innovations in biomaterials, bioresorbable polymers, and tissue engineering have significantly broadened the scope and efficacy of biosurgical products, paving the way for higher adoption rates across multiple specialties.

Increasingly, hospitals and surgical centers are recognizing the clinical and economic benefits of integrating biosurgery products into standard protocols. For instance, the ability of hemostatic agents to reduce operative bleeding not only improves patient safety but also shortens recovery times and reduces overall treatment costs. The same applies to surgical sealants and adhesion barriers, which minimize postoperative complications and lower the likelihood of reoperation. This growing awareness, coupled with favorable reimbursement policies in key healthcare markets, is accelerating demand. Moreover, rising investments in research aimed at developing next-generation biosurgery solutions with enhanced biocompatibility, stronger mechanical performance, and faster resorption profiles are likely to further bolster market expansion over the forecast horizon.

Regionally, North America dominated the market in 2024, supported by its advanced healthcare infrastructure, high surgical procedure volumes, and strong presence of leading medical device manufacturers. The United States, in particular, benefits from rapid technology adoption and a well-established reimbursement framework that incentivizes the use of advanced biosurgical products. Europe follows closely, driven by growing demand for minimally invasive surgeries, an increasing elderly population, and stringent regulatory frameworks that encourage high-quality product development. Meanwhile, the Asia Pacific region is projected to record the fastest growth from 2025 to 2035, fueled by expanding healthcare access, rising medical tourism, and government-led initiatives to modernize surgical facilities in countries such as China, India, and South Korea. Emerging markets in Latin America and the Middle East & Africa are also showing promising potential, as infrastructure development and training programs gradually increase the availability and adoption of advanced biosurgical techniques.

Major market player included in this report are:
• Johnson & Johnson (Ethicon)
• Medtronic plc
• Baxter International Inc.
• Becton, Dickinson and Company (BD)
• Stryker Corporation
• Integra LifeSciences Holdings Corporation
• CSL Limited
• CryoLife, Inc.
• Hemostasis LLC
• Sanofi S.A.
• B. Braun Melsungen AG
• Smith & Nephew plc
• Takeda Pharmaceutical Company Limited
• Zimmer Biomet Holdings, Inc.
• Pfizer Inc.

Global Biosurgery Market Report Scope:
• Historical Data – 2023, 2024
• Base Year for Estimation – 2024
• Forecast period – 2025-2035
• Report Coverage – Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
• Regional Scope – North America; Europe; Asia Pacific; Latin America; Middle East & Africa



The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values for the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within the countries involved in the study. The report also provides detailed information about crucial aspects, such as driving factors and challenges, which will define the future growth of the market. Additionally, it incorporates potential opportunities in micro-markets for stakeholders to invest, along with a detailed analysis of the competitive landscape and product offerings of key players.

The detailed segments and sub-segments of the market are explained below:

By Product:
• Surgical Sealants
• Hemostatic Agents
• Adhesion Barriers
• Soft Tissue Attachments

By Application:
• General Surgery
• Orthopedic Surgery

By Region:

North America
• U.S.
• Canada

Europe
• UK
• Germany
• France
• Spain
• Italy
• ROE

Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• RoAPAC

Latin America
• Brazil
• Mexico

Middle East & Africa
• UAE
• Saudi Arabia
• South Africa
• Rest of Middle East & Africa

Key Takeaways:
• Market Estimates & Forecast for 10 years from 2025 to 2035.
• Annualized revenues and regional level analysis for each market segment.
• Detailed analysis of geographical landscape with Country level analysis of major regions.
• Competitive landscape with information on major players in the market.
• Analysis of key business strategies and recommendations on future market approach.
• Analysis of competitive structure of the market.
• Demand side and supply side analysis of the market.

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions. Show more